KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Gross Margin (2018 - 2026)

ClearPoint Neuro's Gross Margin history spans 13 years, with the latest figure at 61.52% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 24.0% to 61.52% in Q4 2025 year-over-year; TTM through Dec 2025 was 61.38%, a 46.0% increase, with the full-year FY2025 number at 61.38%, up 46.0% from a year prior.
  • Gross Margin hit 61.52% in Q4 2025 for ClearPoint Neuro, down from 63.2% in the prior quarter.
  • Over the last five years, Gross Margin for CLPT hit a ceiling of 74.36% in Q4 2021 and a floor of 52.54% in Q2 2023.
  • Historically, Gross Margin has averaged 62.6% across 5 years, with a median of 62.06% in 2025.
  • Biggest five-year swings in Gross Margin: plummeted -1469bps in 2023 and later skyrocketed 1094bps in 2024.
  • Tracing CLPT's Gross Margin over 5 years: stood at 74.36% in 2021, then fell by -13bps to 65.06% in 2022, then dropped by -9bps to 58.93% in 2023, then increased by 4bps to 61.28% in 2024, then increased by 0bps to 61.52% in 2025.
  • Business Quant data shows Gross Margin for CLPT at 61.52% in Q4 2025, 63.2% in Q3 2025, and 60.29% in Q2 2025.